News
Oppenheimer Initiates Coverage On Xeris Biopharma Holdings with Outperform Rating, Announces Price Target of $5
28 Mar 24
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Xeris Biopharma Holdings, Raises Price Target to $6
7 Mar 24
News, Price Target, Analyst Ratings
Xeris Biopharma Holdings Q4 GAAP EPS $(0.10), Inline, Sales $44.39M Beat $43.55M Estimate
6 Mar 24
Earnings, News
Earnings Scheduled For March 6, 2024
6 Mar 24
Earnings
Earnings Outlook For Xeris Biopharma Holdings
5 Mar 24
Earnings
Press releases
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3 Apr 24
Press Releases
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
6 Mar 24
Press Releases
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
6 Mar 24
Press Releases
Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
5 Feb 24
Press Releases